Implantica AG

OM:IMP A SDB Stock Report

Market Cap: SEK 9.7b

Implantica Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Peter Forsell

Chief executive officer

€204.3k

Total compensation

CEO salary percentage99.8%
CEO tenure10yrs
CEO ownership87.1%
Management average tenure4.5yrs
Board average tenure5yrs

Recent management updates

Recent updates

We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely

Jul 26
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely

We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely

Mar 06
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely

We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth

Aug 19
We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth

We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth

May 05
We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth

We're Not Very Worried About Implantica's (STO:IMP A SDB) Cash Burn Rate

Jan 14
We're Not Very Worried About Implantica's (STO:IMP A SDB) Cash Burn Rate

We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely

Sep 26
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely

Implantica (STO:IMP A SDB) Is In A Strong Position To Grow Its Business

Jan 08
Implantica (STO:IMP A SDB) Is In A Strong Position To Grow Its Business

CEO Compensation Analysis

How has Peter Forsell's remuneration changed compared to Implantica's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-€25m

Jun 30 2024n/an/a

-€24m

Mar 31 2024n/an/a

-€23m

Dec 31 2023€204k€204k

-€24m

Sep 30 2023n/an/a

-€20m

Jun 30 2023n/an/a

-€20m

Mar 31 2023n/an/a

-€21m

Dec 31 2022€200k€200k

-€21m

Compensation vs Market: Peter's total compensation ($USD209.51K) is below average for companies of similar size in the Swedish market ($USD748.66K).

Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.

CEO

Peter Forsell (70 yo)

10yrs

Tenure

€204,274

Compensation

Dr. Peter Forsell founded Implantica AG in 2015 and serves as its Chief Executive Officer since 2015.

Leadership Team

NamePositionTenureCompensationOwnership
Peter Forsell
Founder & CEO10yrs€204.27k87.11%
SEK 8.5b
Andreas Öhrnberg
Chief Financial Officer5yrsno data0.0084%
SEK 821.0k
Stephan Siegenthaler
Chief Strategy Officer & Board Memberno datano data0.32%
SEK 31.0m
Nicole Pehrsson
Chief Corporate Affairs Officer2.6yrsno data0.17%
SEK 16.6m
Amit Kukreja
Chief Market Access & Strategy Officer4yrsno datano data
Jörg von Manger-Koenig
Company Secretary & Member of Advisory Boardno datano datano data

4.5yrs

Average Tenure

61yo

Average Age

Experienced Management: IMP A SDB's management team is considered experienced (4.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Stephan Siegenthaler
Chief Strategy Officer & Board Member5yrsno data0.32%
SEK 31.0m
Jörg von Manger-Koenig
Company Secretary & Member of Advisory Boardno datano datano data
Liselott Kilaas
Independent Chair of the Board5yrs€36.02k0.0099%
SEK 968.1k
Tomas Puusepp
Independent Board Member4.4yrs€50.43k0.0071%
SEK 687.6k
Felix Zulauf
Member of Advisory Boardno datano datano data
Johan Bojs
Vice-Chairman of the Board5yrs€10.29k0.047%
SEK 4.6m
Piet Pattyn
Member of Scientific Advisory Boardno datano datano data
Steven Wilson
Member of Scientific Advisory Boardno datano datano data
Kaspar Z'graggen
Member of Scientific Advisory Boardno datano datano data

5.0yrs

Average Tenure

66yo

Average Age

Experienced Board: IMP A SDB's board of directors are considered experienced (5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 18:41
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Implantica AG is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christian LeePareto Securities
Chien-Hsun LeePareto Securities